Wednesday, September 2, 2026

11:00 AM - 12:30 PM

---

Details

Organised by the FIP The Technology Advisory Group in collaboration with the FIP Academic Pharmacy Section, the FIP Community Pharmacy Section and the FIP Regulatory Advisory Group Chair(s) Dr Sham Moodley, Executive Committee Member, the FIP Community Pharmacy Section, South Africa & Mr Lars-Åke Söderlund, Chair, the FIP Technology Advisory Group, Sweden Introduction: Chronic conditions such as diabetes, hypertension, and asthma remain leading drivers of morbidity, mortality, and healthcare costs worldwide. Despite being one of the most accessible points of contact for patients, pharmacists’ ability to deliver proactive, continuous chronic care has historically been limited by fragmented information systems and lack of real-time patient data. This gap often prevents timely interventions, impedes adherence monitoring, and constrains pharmacists’ role in improving long-term health outcomes. Emerging digital health technologies—including wearables, connected glucometers, blood pressure monitors, smart inhalers, and AI-based analytics—offer new opportunities for pharmacists to participate in continuous patient monitoring. These tools can generate real-time insights, enabling pharmacists to detect trends, identify adherence gaps, provide timely interventions, and personalize care plans. When effectively integrated into routine pharmacy workflows, digital monitoring has the potential to transform chronic disease management, improve patient engagement, and reduce preventable complications. However, the successful adoption of these technologies requires careful attention to responsible implementation. Pharmacists must navigate challenges around data privacy, informed consent, interoperability, and equitable access. Embedding these tools into practice also demands thoughtful workflow design, staff training, and collaboration with healthcare providers, regulators, payers, and technology developers. Education is critical for pharmacists to fully realize this potential. Training ensures that pharmacists: - Understand the capabilities, limitations, and evidence base of digital health tools. - Can interpret patient-generated data accurately to inform clinical decisions. - Apply best practices in privacy, consent, and ethical data management. - Confidently guide patients in using connected devices, improving adherence, self-management, and health literacy. Programme: Learning objectives: 1. Examine how digital monitoring tools can enhance pharmacist-led chronic disease management. 2. Identify practical workflows and interoperability strategies for integrating patient-generated health data. 3. Analyse case studies of tech-supported pharmacy care and evaluate policy, reimbursement, and regulatory frameworks to guide sustainable, evidence-based adoption of digital health solutions. Take home messages: Pharmacists can transform chronic disease management by integrating digital monitoring tools into practice. By interpreting real-time patient data, navigating regulatory frameworks, and applying best practices, they improve adherence, outcomes, and patient engagement. Education and training are essential to ensure responsible, sustainable, and patient-centred adoption of technology in pharmacy care. FIP Development Goals: To learn more about these FIP Development Goals, click on the links below. FIP Development Goal 10: Equity and Equality FIP Development Goal 15: People-Centred Care FIP Development Goal 20: Digital Health

---

Chairs & speakers